Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs
University of Pittsburgh · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT07216118
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 13+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 104
- US sites recruiting
- 1
- Study start
- April 21, 2026
- Record last updated
- April 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to pilot test different strategies to address health related social needs (HRSN) experienced by adolescent and young adult patients with type 2 diabetes and their families. The main questions it aims to answer are:
- How feasible are the strategies?
- How acceptable are the strategies?
- How reliably and consistently can the strategies be implemented?
Participants will
Attend regularly scheduled diabetes clinic visits. Complete surveys and interviews. Be connected to community resources and organizations to help address HRSN.
Being studied: Tailored Resources; Universal Empowerment; Text Messages; Community Health Workers (CHW)
Conditions: Diabetes in Adolescence; Type 2 Diabetes; Social Needs
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Adolescent-Caregiver Dyads will be recruited together.
Adolescent Inclusion Criteria
- Age 13 to 22 years old
- known diagnosis of type 2 diabetes
- followed clinically at UPMC Children's Hospital of Pittsburgh
- able to provide assent/consent
Caregiver Inclusion Criteria
- Adult (18 years or older) identifying as a primary caretaker of an adolescent or young adult with type 2 diabetes
- Has an adolescent/young adult who agrees to participate in the study
- able to provide consent
Exclusion Criteria
- Inability to complete study questionnaires in English
Recruiting US locations
UPMC Children's Hospital of Pittsburgh
Pittsburgh, PA 15224
Site contact: Mary Ellen Vajravelu, MD MSHP · 4126926533
Study contacts (from the official record)
- Mary Ellen Vajravelu, MD MSHP · 412-692-6533 · maryellen.vajravelu@pitt.edu
- Maya I Ragavan, MD MPH MS · maya.ragavan@chp.edu
Similar studies in Pennsylvania
All diabetes studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Ocugen
- Location
- Erie, PA + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
Pharmacogenetics of Response to GLP1R Agonists
University of Maryland, Baltimore
- Location
- Lancaster, PA
- Eligibility basics
- Ages 18–89
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Philadelphia, PA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Eli Lilly and Company
- Location
- Smithfield, PA + 11 other US sites
- Eligibility basics
- Ages 10–17